Thanks for your donation! (that will be matched :)
The Phase 2 trials and FDA's breakthrough therapy designation along shows strong medical value of MDMA, especially in a clinical context with psychotherapy sessions and a trained therapist.
I hope this starts a renaissance in the use of psychedelics to treat, long term (with short term drug applications), many mental conditions.
The Phase 2 trials and FDA's breakthrough therapy designation along shows strong medical value of MDMA, especially in a clinical context with psychotherapy sessions and a trained therapist.
I hope this starts a renaissance in the use of psychedelics to treat, long term (with short term drug applications), many mental conditions.